Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-07-26
2011-07-26
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S105000
Reexamination Certificate
active
07985748
ABSTRACT:
In its many embodiments, the present invention relates to a novel class of phenylmorpholine and phenylthiomorpholine compounds useful as α2C adrenergic receptor agonists, pharmaceutical compositions containing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the α2C adrenergic receptor agonists using such compounds or pharmaceutical compositions.
REFERENCES:
patent: 5977134 (1999-11-01), Ciccarone et al.
patent: 6673337 (2004-01-01), Olejnik et al.
patent: 7700592 (2010-04-01), McCormick et al.
patent: 2003/0087962 (2003-05-01), Demopulos et al.
patent: WO 97/12874 (1997-04-01), None
patent: WO 97/16727 (1997-05-01), None
patent: WO 97/30992 (1997-08-01), None
patent: WO 99/28300 (1999-06-01), None
patent: WO 01/00586 (2001-01-01), None
patent: WO 02/076950 (2002-10-01), None
patent: WO 03/099795 (2003-12-01), None
patent: WO 2004/050635 (2004-06-01), None
patent: WO 2005/089515 (2005-09-01), None
patent: WO 2007/024949 (2007-03-01), None
R. P. Ahlquist, “A Study of the Adrenotropic Receptors”, Am. J. Physiol., (1948), pp. 586-600, vol. 153.
Arnold et al., “Differentiation of Receptor Systems Activated by Sympathomimetic Amines”, Nature, (1967), pp. 597-598. vol. 214.
Anderson et al., “Preparation of Water-Soluble Compounds Through Salt Formulation”, The Practice of Medicinal Chemistry, Academic Press, New York (1996), pp. 739-754.
Bagley et al., “Synthesis and Alpha 2 Adrenergic Activities of lmidazole and Imidazolidine Analogues, In Vitro and in Vivo Selectivity”, Medicinal Chemistry Research, Birkahuser, Boston, US, (1994), pp. 346-364, vol. 4, No. 5.
Berge et al., Journal of Pharmaceutical Salts, (1977), pp. 1-19, vol. 66 (1).
Bousquet et al., “Role of the Ventral Surface of the Brain Stem in the Hypotensive Action of Clonidine”, European Journal of Pharmacology, (1975), pp. 151-156, vol. 34.
P. Bousquet et al., “Imidazoline Receptors: From Basic Concepts to Recent Developments”, Journal of Cardiovascular Pharmacology. (1995), pp. S1-S6, vol. 26 (Suppl. 2).
Chang et al., Microwave-Assisted Soluble Polymer-Supported Synthesis of Benzopiperazinones, Synlett, (2003), pp. 1688-1692, vol. 11.
Feng et al., “One-Pot Regioselective Annulation Toward 3,4-Dihydro-3-Oxo-2H-1,4-Benzoxazine Scaffolds Under Controlled Microwave Heating”, Tetrahedron. (2006), pp. 4635-4642, vol. 62.
Gould et al., International Journal of Pharmaceutics (1986), pp. 201-217, vol. 33.
Greene et al., Protective Groups in Organic Synthesis, (1991), Wiley, New York.
T. Higuchi et al., “Pro-Drugs as Novel Delivery System”, A.C.S. Symposium Series, (1975) vol. 14.
Lands et al., “Differentiation of Receptor Systems Activated by Sympathomimetic Amines”, Nature, (1976), pp. 597-598, vol. 214.
Macdonald et al., “Gene Targeting-Homing in on Alpha2-Adrenoceptors-Subtype Function”, TIPS, (1997), pp. 211-219, vol. 18.
Michel et al., “Classification of Alpha 1-Adrenoceptor Subtypes”, Naunyn-Schmiedeberg's Arch Pharmacol., (1995). pp. 1-10, vol. 352.
Reis et al., “The Imidazoline Receptor Pharmacology, Functions, Ligands, and Relevance to Biology and Medicine”, Annals of the New York Academy of Sciences, (1995), vol. 763, Table of Contents.
Roche et al., Bioreversible Carriers in Drug Design, American Pharmaceutical Association and Pergamon Press, (1987).
Written Opinion of the International Searching Authority for PCT/US2008/001778)-AL06356-01, 10 Pages, (2008).
International Search Report (PCT/US2008/001776) for AL06356-01 mail date Feb. 7, 2008, 6 pages, (2008).
Written Opinion of the International Searching Authority for (PCT/US2006/032917)-AL06356, 8 pages, (2006).
International Search Report (PCT/US2006/032917) for AL06356 mail date Mar. 20, 2007, 7 pages, (2006).
Aslanian Robert G.
Biju Purakkattle
Boyce Christopher W.
de Lera Ruiz Manuel
Guise-Zawacki Lisa
Devlin Gerard
Fischer H. Eric
Habte Kahsay T
Pharmacopeia Drug Discovery Inc.
Scheeing Corporation
LandOfFree
ALPHA2C adrenoreceptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with ALPHA2C adrenoreceptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ALPHA2C adrenoreceptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2619005